We are honored to have given our first official pitch with Transire Bio at the top 50 of W.A. De Vigier Award. We were selected among 310 applicants and we will have a chance to pitch in Soloturn in the Life Sciences & Biotech & Pharma cluster.
Read the press release at https://devigier.ch/press-release-selection-day-top50-2023/. Learn more about Bil De Vigier and W.A. De Vigier Foundation at https://devigier.ch/.
Related items
OBaris is excited to share that we joined the Swiss National Startup Team! Represented by
OBaris wins Stage III Venture Kick and receives additional CHF 100’000! Read the announcem
OBaris receives CHF 150’000 for the accelerated market entry from Gebert Rüf Foundation! A